Lv Guangyao, Yang Menglin, Gai Keke, Jia Qiong, Wang Zhenzhen, Wang Bin, Li Xueying
Department of Pharmacy, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Quality Management Department, Marine Biomedical Research Institute of Qingdao, Qingdao, China.
Front Oncol. 2024 Apr 25;14:1384109. doi: 10.3389/fonc.2024.1384109. eCollection 2024.
High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.
高迁移率族蛋白B1(HMGB1)是一种核DNA结合蛋白,在癌症中具有双重作用,既是癌基因又是肿瘤抑制因子。该蛋白调节细胞内核小体结构、DNA损伤修复和基因组稳定性,同时也在免疫细胞功能中发挥作用。本综述全面评估了HMGB1在癌症中的生物学和临床意义,包括其在细胞死亡和存活中的作用、作为治疗靶点和癌症生物标志物的潜力,以及作为细胞毒性抗癌治疗后剩余细胞的促存活信号。我们强调需要更好地理解HMGB1参与癌症的细胞标志物和机制,旨在更深入地了解其在癌症进展中的作用。